[HTML][HTML] Putting evidence into practice®: evidence-based interventions for the management of oral mucositis
D Harris - Number 1/February 2008, 2008 - cjon.ons.org
Methods The team searched MEDLINE®, the US National Library of Medicine's
bibliographic database, CINAHL®(Cumulative Index to Nursing and Allied Health Literature) …
bibliographic database, CINAHL®(Cumulative Index to Nursing and Allied Health Literature) …
Clinical update: prevention and management of oral mucositis in patients with cancer
J Eilers, R Million - Seminars in oncology nursing, 2011 - Elsevier
OBJECTIVES: To present a clinical update of evidence that applies to the development of a
nursing plan of care for the prevention and treatment of oral mucositis related to cytotoxic …
nursing plan of care for the prevention and treatment of oral mucositis related to cytotoxic …
Honey and a mixture of honey, beeswax, and olive oil–propolis extract in treatment of chemotherapy-induced oral mucositis: a randomized controlled pilot study
M Abdulrhman, N Samir Elbarbary… - Pediatric hematology …, 2012 - Taylor & Francis
In spite of being one of the most investigated subjects among supportive care in cancer, no
therapy has been found effective in treatment of chemotherapy-induced oral mucositis …
therapy has been found effective in treatment of chemotherapy-induced oral mucositis …
Effects of laser irradiation at different wavelengths (660, 810, 980, and 1,064 nm) on mucositis in an animal model of wound healing
The aim of the present study was to compare the effectiveness of four different laser
wavelengths (660, 810, 980, and 1,064 nm) used for low-level laser therapy (LLLT) on the …
wavelengths (660, 810, 980, and 1,064 nm) used for low-level laser therapy (LLLT) on the …
Guidelines for the assessment of oral mucositis in adult chemotherapy, radiotherapy and haematopoietic stem cell transplant patients
B Quinn, CMJ Potting, R Stone, NMA Blijlevens… - European Journal of …, 2008 - Elsevier
Oral mucositis (OM) is a serious consequence of some chemotherapy and radiotherapy
regimens. A number of reliable instruments are available to assess OM, but none are …
regimens. A number of reliable instruments are available to assess OM, but none are …
Cancer patients with oral mucositis: challenges for nursing care
SNM Araújo, MHBA Luz, GRF Silva… - … latino-americana de …, 2015 - SciELO Brasil
OBJECTIVE: to analyze nursing care provided to cancer patients with oral mucositis based
on the Nursing Process (NP). METHOD: this exploratory, descriptive, cross-sectional and …
on the Nursing Process (NP). METHOD: this exploratory, descriptive, cross-sectional and …
Effect of adding the herb Achillea millefolium on mouthwash on chemotherapy induced oral mucositis in cancer patients: a double-blind randomized controlled trial
S Miranzadeh, M Adib-Hajbaghery… - European Journal of …, 2015 - Elsevier
Background Oral mucositis (OM) is a debilitating side-effect of chemotherapy. It has different
complications, including impairment of drinking, eating and even talking, sometimes so …
complications, including impairment of drinking, eating and even talking, sometimes so …
Prevention and management of oral mucositis in patients with cancer
J Eilers, R Million - Seminars in oncology nursing, 2007 - Elsevier
OBJECTIVES: To review current evidence that applies to the development of a nursing plan
of care for the prevention and treatment of oral mucositis related to cytotoxic therapy. DATA …
of care for the prevention and treatment of oral mucositis related to cytotoxic therapy. DATA …
Knowledge, perceived ability and practice behaviors regarding oral health among pediatric hematology and oncology nurses
AD Perry, H Iida, LL Patton, RS Wilder - American Dental Hygienists' …, 2015 - jdh.adha.org
Purpose: Oral complications are common in children undergoing head and neck radiation
and chemotherapy. The purpose of this study is to examine the knowledge, perceived ability …
and chemotherapy. The purpose of this study is to examine the knowledge, perceived ability …
Management of adverse events in patients with hormone receptor-positive breast cancer treated with everolimus: observations from a phase III clinical trial
ME Peterson - Supportive Care in Cancer, 2013 - Springer
Everolimus is a mammalian target of rapamycin (mTOR) inhibitor approved for the treatment
of advanced renal cell carcinoma, pancreatic neuroendocrine tumors, subependymal giant …
of advanced renal cell carcinoma, pancreatic neuroendocrine tumors, subependymal giant …